NASDAQ:OVID | Cash Flow Statement | Ovid Therapeutics Inc.

Complete source-backed cash-flow history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$15.01M
2026-03-31-$16.99M$35,000.00-$13.9M$5.95M$88.98M
2025-12-31$9.66M$17,000.00-$10.41M$0.00-$72.06M$75.18M
2025-09-30-$12.16M
2025-06-30-$4.68M
2025-03-31-$10.24M$141,000.00-$10.28M$0.00$5.1M$13,000.00
2024-12-31-$9.25M$160,000.00-$10.01M$22,000.00$21.29M$0.00
2024-09-30-$14.01M
2024-06-30$8.52M
2024-03-31-$11.69M$136,000.00-$16.69M$19,000.00$20.19M$228,000.00
2023-12-31-$15.32M$140,000.00-$11.91M$13,000.00-$48.52M$30.03M
2023-09-30-$11.25M
2023-06-30-$12.41M
2023-03-31-$13.36M$145,000.00-$12.11M$14,000.00$30.23M$67,000.00
2022-12-31-$11.5M$184,980.00-$9.18M$119,939.00-$4.17M-$43,599.00
2022-09-30-$11.97M
2022-06-30-$14.59M
2022-03-31-$16.11M$73,807.00-$20.09M$45,935.00-$1.08M$33,079.00
2021-12-31-$26M$56,951.00-$12M$161,958.00-$161,958.00$109,180.00
2021-09-30-$11.38M
2021-06-30-$15.79M
2021-03-31$176.01M$74,735.00$160.9M$11,514.00-$11,514.00$129,661.00
2020-12-31-$22.03M$83,041.00-$14.51M$41,883.00-$90,481.00-$232,482.00
2020-09-30-$16.42M
2020-06-30-$22.55M
2020-03-31-$20.03M$66,879.00-$18.41M$14,139.00$3.84M$15,535.00
2019-12-31-$16.97M$53,801.00-$16.89M$31,245.00-$35.01M$55.89M
2019-09-30-$16.63M
2019-06-30-$13.06M
2019-03-31-$13.8M$76,535.00-$12.87M$4,324.00-$8,974.00$30.99M
2018-12-31-$12.9M$55,292.00-$10.97M-$5,621.00$16.94M$2.00
2018-09-30-$12.96M
2018-06-30-$12.94M
2018-03-31-$13.18M$26,372.00-$12.93M$7,581.00-$45.07M$75,401.00
2017-12-31-$10.96M$21,720.00-$9.01M$7,802.00$61,706.00$27,043.00
2017-09-30-$9.36M
2017-06-30-$10.25M
2017-03-31-$34.24M$18,463.00-$7.16M$12,131.00
2016-12-31-$7.56M$32,757.00-$5.71M$3,426.00
2016-09-30-$5.79M
2016-06-30-$5.39M
2016-03-31-$3.68M$5,896.00-$3.84M$14,653.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$17.41M$273,000.00-$38.33M$0.00-$49.85M$75.21M
2024-12-31-$26.43M$613,000.00-$55.96M$71,000.00$54.59M$622,000.00
2023-12-31-$52.34M$568,000.00-$45.78M$40,000.00-$2.58M$30.54M
2022-12-31-$54.17M$512,505.00-$55.23M$1.22M-$87.88M$180,658.00
2021-12-31$122.83M$237,079.00$118.61M$184,008.00-$1.82M$904,082.00
2020-12-31-$81.04M$306,848.00-$51.58M$127,240.00$34.65M$47.07M
2019-12-31-$60.46M$255,002.00-$51.09M$57,156.00-$30.04M$86.54M
2018-12-31-$51.98M$141,733.00-$45.56M$33,871.00-$5.36M$286,140.00
2017-12-31-$64.81M$80,310.00-$31.47M$38,907.00-$47,387.00$66.7M
2016-12-31-$22.41M$56,512.00-$17.8M$30,364.00
2015-12-31-$13.16M$11,778.00-$5.49M$32,082.00